Quick Answer
ORAMED PHARMACEUTICALS INC. reported Total Assets of $230.86 million for fiscal year 2025.
ORAMED PHARMACEUTICALS INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $230.86M | +48.7% |
| 2024 | $155.28M | -29.6% |
| 2023 | $220.55M | +36.4% |
| 2022 | $161.64M | -9.1% |
| 2021 | $177.82M | +38.9% |
| 2021 | $128.00M | +186.8% |
| 2020 | $44.63M | +28.8% |
| 2019 | $34.66M | -26.9% |
| 2018 | $47.40M | +22.4% |
| 2017 | $38.71M | -9.6% |
| 2016 | $42.83M | +62.5% |
| 2015 | $26.35M | +20.9% |
| 2014 | $21.80M | +151.8% |
| 2013 | $8.66M | +63.6% |
| 2012 | $5.29M | +22.4% |
| 2011 | $4.33M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $220.49M | +33.6% | +36.4% |
| June 30, 2025 | $161.68M | -12.2% | +9.6% |
| March 31, 2025 | $147.54M | -27.6% | -5.0% |
| December 31, 2024 | $155.28M | -29.6% | -5.9% |
| September 30, 2024 | $165.08M | -28.5% | -10.4% |
| June 30, 2024 | $184.22M | +17.9% | -9.5% |
| March 31, 2024 | $203.65M | +27.5% | -7.7% |
| December 31, 2023 | $220.55M | +36.4% | -4.5% |
- ORAMED PHARMACEUTICALS INC. showed an increase of +48.7% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, ORAMED PHARMACEUTICALS INC.’s total assets has grown by 5236.7% (from $4.33 million to $230.86 million).
- The most recent figure is from ORAMED PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: